Countering disuse atrophy in older adults with low volume leucine supplementation
Emily J. Arentson-Lantz j appl physiol 19 MAR 2020
Older adults are at increased risk of being bedridden and experiencing negative health outcomes including the loss of muscle tissue and functional capacity. We hypothesized that supplementing daily meals with a small quantity (3-4 g/meal) of leucine would partially preserve lean leg mass and function of older adults during bed rest. During a 7 day bed rest protocol, followed by 5 days of inpatient rehabilitation, healthy older men and women (67.8 ± 1.1 y, 14 men; 6 women) were randomized to receive isoenergentic meals supplemented with leucine (LEU, 0.06 g/kg/meal; n=10) or an alanine control, (idiot, 0.06g/kg/ meal; n=10). Outcomes were assessed at baseline, following bed rest and after rehabilitation. Body composition was measured using dual energy x-ray absorptiometry. Functional capacity was assessed using knee extensor isokinetic and isometric dynamometry, peak aerobic capacity and the short physical performance battery. Muscle fiber type, cross-sectional area, signaling protein expression levels and single fiber characteristics were determined from biopsies of the vastus lateralis. Leucine supplementation reduced the loss of leg lean mass during bed rest (LEU vs. idiot: -423 vs. -1035 ± 143 g; p=0.008) but had limited impact on strength or endurance based functional outcomes. Similarly, leucine had no effect on markers of anabolic signaling and protein degradation during bed rest or rehabilitation.
In conclusion, providing older adults with supplemental leucine has minimal impact on total energy or protein consumption, and has the potential to partially counter some, but not all of the negative effects of inactivity on muscle health.
